
zzso is the most frequent primary zzso brain tumor in zzso zzso zzso zzso with zzso and zzso chemotherapy with zzso is the standard treatment, however the prognosis remains poor with a median survival in the range of zzso zzso In recent years, several targeted agents have been developed as potential zzso of molecular genetic and signal zzso pathways involved in zzso including those of vascular zzso growth factor and its zzso zzso growth factor zzso zzso and zzso target of zzso The zzso are a family of zzso zzso receptors that mediate cell zzso and zzso zzso and are widely expressed in zzso cells and tumor zzso The critical role of zzso in zzso cell invasion and migration make them an attractive target for zzso zzso zzso peptides and zzso zzso to zzso are currently being investigated in clinical trials in patients with solid tumors, such as zzso cancer, zzso cell zzso and zzso zzso a zzso zzso zzso that selectively blocks zzso of the zzso and zzso zzso has shown encouraging activity in patients with zzso as single agent, and in association with standard zzso and zzso In this review, we provide a brief overview of the zzso experience and current clinical results of zzso therapy in patients with zzso or newly diagnosed zzso 

